We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
Cap. Flow
+$859M
Cap. Flow %
5.88%
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$135M
2
RY icon
Royal Bank of Canada
RY
+$120M
3
A icon
Agilent Technologies
A
+$72.5M
4
UNH icon
UnitedHealth
UNH
+$71.5M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$64.2M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$90.3M
2
AMGN icon
Amgen
AMGN
+$88.7M
3
ALL icon
Allstate
ALL
+$52.2M
4
UNP icon
Union Pacific
UNP
+$47.1M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$44.7M

Sector Composition

Rank Sector Weight
1 Healthcare 33.42%
2 Technology 23.2%
3 Consumer Discretionary 9.14%
4 Financials 8.63%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTRA
876
DELISTED
Coterra Energy
CTRA
– –
-149,580
Closed -$2.34M
CVE icon
877
Cenovus Energy
CVE
$52.9B
– –
-12,886
Closed -$75K
CX icon
878
Cemex
CX
$17.6B
– –
-76,375
Closed -$377K
ENTA icon
879
Enanta Pharmaceuticals
ENTA
$379M
– –
-178,941
Closed -$7.24M
EPAM icon
880
EPAM Systems
EPAM
$4.92B
– –
-25,300
Closed -$8.71M
EQH icon
881
Equitable Holdings
EQH
$13.2B
– –
-12,310
Closed -$303K
FBIN icon
882
Fortune Brands Innovations
FBIN
$6.15B
– –
-4,337
Closed -$305K
FFIV icon
883
F5
FFIV
$22.6B
– –
-84,236
Closed -$14.2M
FICO icon
884
Fair Isaac
FICO
$30.1B
– –
-16,389
Closed -$8.04M
FOLD
885
DELISTED
Amicus Therapeutics
FOLD
– –
-615,124
Closed -$13.6M
FSLR icon
886
First Solar
FSLR
$21.8B
– –
-30,405
Closed -$2.89M
IMVT icon
887
Immunovant
IMVT
$8.27B
– –
-181,749
Closed -$8.06M
KB icon
888
KB Financial Group
KB
$41.4B
– –
-6,776
Closed -$258K
KZR
889
DELISTED
Kezar Life Sciences
KZR
– –
-58,496
Closed -$2.93M
LOOP icon
890
Loop Industries
LOOP
$36.7M
– –
-103,898
Closed -$828K
M icon
891
Macy's
M
$6.49B
– –
-25,000
Closed -$269K
MCHI icon
892
iShares MSCI China ETF
MCHI
$6.14B
– –
-15,000
Closed -$1.16M
MDGL icon
893
Madrigal Pharmaceuticals
MDGL
$12.8B
– –
-31,722
Closed -$3.39M
MFG icon
894
Mizuho Financial
MFG
$128B
– –
-18
Closed –
MUFG icon
895
Mitsubishi UFJ Financial
MUFG
$259B
– –
-230
Closed -$1K
NKTR icon
896
Nektar Therapeutics
NKTR
$2.37B
– –
-20,406
Closed -$5M
NKTX icon
897
Nkarta
NKTX
$170M
$0 ﹤0.01%
4
-67,142
-100% -$1.93M
PKX icon
898
POSCO
PKX
$16B
– –
-3,720
Closed -$223K
RCKT icon
899
Rocket Pharmaceuticals
RCKT
$359M
– –
-128,749
Closed -$6.78M
RCUS icon
900
Arcus Biosciences
RCUS
$3.57B
– –
-408,991
Closed -$10.2M
34 35
36
37 38

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2021 Portfolio in Review

As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.

  • Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
  • Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
  • Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
  • Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
  • Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
  • Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.

Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.